Fig. 3: Forest plots of hazard ratios (HRs) in the maintenance setting.
From: Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
(a) HRs for progression-free survival and (b) HRs for overall survival of bortezomib-based regimen vs. control. HRs for each trial are represented by squares, where the size of the square represents the weight of the trial in the meta-analysis and the horizontal line crossing the square represents the 95% confidence interval (CI). The diamonds represent the overall summary HR estimates and 95% CIs.
